ACUTE-ON-CHRONIC LIVER FAILURE
Clinical trials for ACUTE-ON-CHRONIC LIVER FAILURE explained in plain language.
Never miss a new study
Get alerted when new ACUTE-ON-CHRONIC LIVER FAILURE trials appear
Sign up with your email to follow new studies for ACUTE-ON-CHRONIC LIVER FAILURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver failure drug trial halted early
Disease control TerminatedThis study tested a drug called VS-01, given into the belly, for people with severe liver failure and fluid buildup (ascites). The goal was to see if it could improve liver function and survival when added to standard care. The trial was stopped early and included only 15 adults.
Matched conditions: ACUTE-ON-CHRONIC LIVER FAILURE
Phase: PHASE2 • Sponsor: Genfit • Aim: Disease control
Last updated May 17, 2026 11:17 UTC
-
Liver failure treatment study halted early
Disease control TerminatedThis study looked at whether a blood-cleaning procedure called plasma exchange (using albumin) could help people with sudden severe liver failure survive longer. It involved 275 adults with high-risk liver failure who were randomly assigned to get either standard care plus plasma…
Matched conditions: ACUTE-ON-CHRONIC LIVER FAILURE
Phase: PHASE3 • Sponsor: Grifols Therapeutics LLC • Aim: Disease control
Last updated May 15, 2026 11:55 UTC